{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-PHTWTXL4/66ea30c3-4776-49b1-94c8-87c87266db17/PDF","dcterms:extent":"327 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-PHTWTXL4/a9227555-6d05-46c8-b97d-9e266a183144/TEXT","dcterms:extent":"19 KB"}],"edm:TimeSpan":{"@rdf:about":"2005-2025","edm:begin":{"@xml:lang":"en","#text":"2005"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-PHTWTXL4","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN"},{"@xml:lang":"sl","#text":"Farmacevtski vestnik"}],"dcterms:issued":"2015","dc:creator":"Obreza, Aleš","dc:format":[{"@xml:lang":"sl","#text":"številka:2"},{"@xml:lang":"sl","#text":"letnik:66"},{"@xml:lang":"sl","#text":"str. 209-214"}],"dc:identifier":["ISSN:0014-8229","COBISSID:3859313","URN:URN:NBN:SI:doc-PHTWTXL4"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"dc:subject":[{"@xml:lang":"sl","#text":"antiandogeni"},{"@xml:lang":"sl","#text":"antiholinergiki"},{"@xml:lang":"sl","#text":"gonadoliberinski receptorji"},{"@xml:lang":"sl","#text":"mirabegron"},{"@xml:lang":"sl","#text":"prekomerna aktivnost sečnega mehurja"},{"@xml:lang":"sl","#text":"prostata"},{"@xml:lang":"en","#text":"prostate"},{"@xml:lang":"sl","#text":"rak (medicina)"},{"@xml:lang":"sl","#text":"taksani"},{"@rdf:resource":"http://www.wikidata.org/entity/Q9625"}],"dcterms:temporal":{"@rdf:resource":"2005-2025"},"dc:title":{"@xml:lang":"sl","#text":"Zdravila za zdravljenje bolezni prostate in mehurja| Drugs for treating diseases of prostate and bladder|"},"dc:description":[{"@xml:lang":"sl","#text":"The most important active ingredients for alleviating symptoms of overactive bladder and treating prostatic cancer are presented in the paper. The manuscript complements the articles on the treatment of benign prostatic hyperplasia, published in the December issue of the Slovenian professional journal Farmacevtski vestnik"},{"@xml:lang":"sl","#text":"V prispevku je predstavljen pregled zdravilnih učinkovin za lajšanje težav pri prekomerni aktivnosti sečnega mehurja in raku prostate. Prispevek dopolnjuje članka o zdravljenju benigne hiperplazije prostate, objavljena v decembrski številki Farmacevtskega vestnika, 2014"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-PHTWTXL4","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-PHTWTXL4"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-PHTWTXL4/66ea30c3-4776-49b1-94c8-87c87266db17/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko farmacevtsko društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-PHTWTXL4/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-PHTWTXL4"}}}}